National, Randomized, Phase II Study Comparing Efficacy of Weekly Administration of Paclitaxel in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse
The main purpose of this research study is to find out if treatment of early relapse of
ovarian or fallopian tube or peritoneal cancer with paclitaxel (Taxol*) weekly administered,
in lower doses in combination with topotecan (Hycamtin*) or carboplatin will improve
efficacy compared to weekly administration of paclitaxel in monotherapy. Tolerance in the
three groups will be compared.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Progression-free survival of patients in the three groups
Laure Chauvenet, MD, PhD
Study Director
Hôpital Hôtel Dieu
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
CAR\TAXHY
NCT00189566
April 2004
April 2009
Name | Location |
---|